How will GlaxoSmithKline keep teenagers from buying the COMMIT Lozenge and abusing it?
The COMMIT Lozenge does not have any inherent appeal among teens and no characteristics for teen “fad” use, such as an immediate “euphoric” effect. Additionally, the cost of the product makes it unlikely that teens would want to use it. GSK already has in place a program of retailer education and has established incentives designed to ensure that the COMMIT Lozenge is not sold to persons under the age of 18. GSK also has developed a comprehensive post-marketing surveillance strategy to help identify and correct any such off-label use.
